Alumexx NV (XAMS:ALX) Other Long-Term Liabilities: €9.50 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XAMS:ALX Alumexx NV XAMS:ALX
71 GF Score
Price €1.38
GF Value €1.67
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Alumexx NV Other Long-Term Liabilities?

Alumexx NV XAMS:ALX -1.43% 71 Other Long-Term Liabilities is €9.50 Mil as of Dec. 2025. GuruFocus rates XAMS:ALX with a GF Score™ of 71/100 and a GF Value™ of €1.67 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Alumexx NV's other long-term liabilities for the quarter that ended in Dec. 2025 was €9.50 Mil.

Alumexx NV's quarterly other long-term liabilities declined from Dec. 2024 (€9.31 Mil) to Jun. 2025 (€1.27 Mil) but then increased from Jun. 2025 (€1.27 Mil) to Dec. 2025 (€9.50 Mil).

Alumexx NV's annual other long-term liabilities declined from Dec. 2023 (€9.57 Mil) to Dec. 2024 (€9.31 Mil) but then increased from Dec. 2024 (€9.31 Mil) to Dec. 2025 (€9.50 Mil).


Alumexx NV Other Long-Term Liabilities Related Terms


Alumexx NV Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Alumexx NV's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alumexx NV Other Long-Term Liabilities Chart

Alumexx NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.07 9.57 9.31 9.50

Alumexx NV Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.57 11.32 9.31 1.27 9.50
XAMS:ALX
71GF Score
Alumexx NV XAMS:ALX
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alumexx NV Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of €9.50 Mil mean?
Alumexx NV (XAMS:ALX) has a Other Long-Term Liabilities of €9.50 Mil as of Dec. 2025. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Alumexx NV and its competitors.
Is Alumexx NV's Other Long-Term Liabilities too high?
Alumexx NV's current Other Long-Term Liabilities is €9.50 Mil. Overall, Alumexx NV has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alumexx NV's Other Long-Term Liabilities compare to AMZN and BABA?
Alumexx NV's Other Long-Term Liabilities of €9.50 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Retail - Cyclical company?
A good Other Long-Term Liabilities depends on the Retail - Cyclical industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Alumexx NV and its competitors. Alumexx NV's current Other Long-Term Liabilities is €9.50 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alumexx NV stock overvalued right now?
Based on GuruFocus' analysis, Alumexx NV (XAMS:ALX) is currently considered Modestly Undervalued. The stock's GF Value™ is €1.67, compared to a current price of €1.38 — trading 17.4% below its estimated fair value. The current Other Long-Term Liabilities is €9.50 Mil. Alumexx NV's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Alumexx NV (XAMS:ALX), the current Other Long-Term Liabilities is €9.50 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alumexx NV (XAMS:ALX) Overvalued in 2026?

Based on GuruFocus' analysis, Alumexx NV stock appears to be undervalued. The current stock price of €1.38 is trading 17.4% below its estimated GF Value™ of €1.67. GuruFocus considers Alumexx NV to be Modestly Undervalued.

Key valuation signals for XAMS:ALX:

  • Other Long-Term Liabilities: €9.50 Mil
  • GF Value™: €1.67 vs. price of €1.38 (17.4% below fair value)
  • GF Score™: 71/100 with 6 warning signs

No single metric tells the full story. See the XAMS:ALX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alumexx NV Business Description

Other Exchanges NE8F:Germany
Address Leerlooierstraat 30, Etten-Leur, NB, NLD, 4871 EN
Alumexx NV is engaged in manufacturing and selling of climbing materials. It focuses on the production and supply of aluminium ladders, steps, scaffolding, and related articles for DIY, painting, and maintenance work at height. The target group is the industrial, semi-professional, and do-it-yourself markets.
71GF Score

Get the complete analysis for XAMS:ALX

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.38
Price
€1.67
GF Value